Durability of Nevirapine-Based Antiretroviral Regimen
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
Although nevirapine is used as an alternative to efavirenz for initial regimen in developed
countries, nevirapine has still been a key antiretroviral drug in many resource-limited
countries including Thailand due to its accessibility and affordability. In addition, a
component of stavudine and lamivudine is still widely used as a backbone in the
antiretroviral regimen in this setting.To date, data on the durability of a regimen of
stavudine, lamivudine and nevirapine are very limited, particularly from the resource-limited
settings.